Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMC Developmental Biology|April 12, 2008
Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergenceAngela J Dibenedetto, Jake B Guinto, Timothy D Ebert, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 1999
Tumor burden and clonality in multiple intestinal neoplasia mouse/normal mouse aggregation chimerasM R Novelli, H Wasan, I Rosewell, et al.
Allergy and Asthma Proceedings|June 17, 2020
An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trialDavid M Fleischer, Sharon Chinthrajah, Amy M Scurlock, et al.
International Journal of Molecular Sciences|July 2, 2021
Genetic and Epigenetic Variations of HPV52 in Cervical PrecancerKatharine J Bee, Ana Gradissimo, Zigui Chen, et al.
Allergy and Asthma Proceedings|June 11, 2020
Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergyDavid M Fleischer, Jonathan M Spergel, Edwin H Kim, et al.
Cardiovascular Research|November 17, 2007
A KCNE2 mutation in a patient with cardiac arrhythmia induced by auditory stimuli and serum electrolyte imbalanceEarl Gordon, Gianina Panaghie, Liyong Deng, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbiditiesCarla M Davis, Lars Lange, Kirsten Beyer, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 9, 2025
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-allergic Children with Atopic ComorbiditiesAmy M Scurlock, David M Fleischer, George Du Toit, et al.
JAMA Pediatrics|February 26, 2024
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical TrialDaniel Petroni, Philippe Bégin, J Andrew Bird, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 1, 2025
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)Jacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, et al.
Pageof 3